Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Gut microbiota: a new way to take your vitamins

IBD is associated with disruptions to resident microbial populations and inflammatory immune responses; however, little is known about how bacteria influence pathogenic immunity. New research identifies microbially produced ascorbate as a potential drug target to ameliorate disease by inhibiting inflammatory T cell function through altered cellular metabolism.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Fig. 1: Putative mechanism for ascorbate-mediated CD4+ T cell function inhibition.


  1. 1.

    Huttenhower, C., Kostic, A. D. & Xavier, R. J. Inflammatory bowel disease as a model for translating the microbiome. Immunity 40, 843–854 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  2. 2.

    Petersen, C. & Round, J. L. Defining dysbiosis and its influence on host immunity and disease. Cell. Microbiol. 16, 1024–1033 (2014).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  3. 3.

    Morgan, X. C. et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 13, R79 (2012).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  4. 4.

    Chang, Y.-L. et al. A screen of Crohn’s disease-associated microbial metabolites identifies ascorbate as a novel metabolic inhibitor of activated human T cells. Mucosal Immunol. (2018).

    Article  PubMed  Google Scholar 

  5. 5.

    Drouin, G., Godin, J. R. & Page, B. The genetics of vitamin C loss in vertebrates. Curr. Genomics 12, 371–378 (2011).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  6. 6.

    Maloy, K. J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298–306 (2011).

    Article  PubMed  CAS  Google Scholar 

  7. 7.

    Chen, Q. et al. Ascorbate in pharmacologic concentrations selectively generates ascorbate radical and hydrogen peroxide in extracellular fluid in vivo. Proc. Natl Acad. Sci. USA 104, 8749–8754 (2007).

    Article  PubMed  CAS  Google Scholar 

  8. 8.

    Krausgruber, T. et al. T-Bet is a key modulator of IL-23-driven pathogenic CD4+ T cell responses in the intestine. Nat. Commun. 7, 11627 (2016).

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  9. 9.

    Vera, J. C. et al. Resolution of the facilitated transport of dehydroascorbic acid from its intracellular accumulation as ascorbic acid. J. Biol. Chem. 270, 23706–23712 (1995).

    Article  PubMed  CAS  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to June L. Round.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Gomes-Neto, J.C., Round, J.L. Gut microbiota: a new way to take your vitamins. Nat Rev Gastroenterol Hepatol 15, 521–522 (2018).

Download citation

Further reading


Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing